Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ertapenem vs Ceftriaxone in Pediatric Infections
NCT00451386Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jan 2002
- Primary completion
- Dec 2003
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ertapenem in complicated urinary tract infection (cUTI), skin and soft tissue infection (SSTI), community acquired pneumonia (CAP), sponsored by Merck & Co.. Started Jan 2002; status: completed.
02
Drugs
ertapenem
03
Conditions
complicated urinary tract infection (cUTI)skin and soft tissue infection (SSTI)community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT00451386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00451386.